Followers | 252 |
Posts | 50375 |
Boards Moderated | 41 |
Alias Born | 08/29/2007 |
Sunday, July 23, 2023 4:03:53 PM
GoSymbol lookup
Health Care : Health Care Technology | Small Cap Growth | Based in United KingdomCompany profile
Renalytix plc is an artificial intelligence-enabled in vitro diagnostics company. The Company is focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care. Its diagnostic platform, KidneyIntelX, is designed to scale across kidney disease conditions beyond diabetic kidney disease. KidneyIntelX is a bioprognostic methodology. The Company is evaluating a range of new indications in chronic kidney disease, cardio-renal disease, chronic kidney disease in diverse populations, and coronavirus disease (COVID)-related kidney disease. KidneyIntelX platform facilitates the identification and promotes the effective management of patients at risk of early-stage diabetic kidney disease (DKD), progression by combining diverse data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record (HER) using a proprietary algorithm to generate a unique patient risk score.
This security is an American depositary receipt
ADR Fees
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent RNLX News
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/15/2024 02:09:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 01:23:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 11:20:02 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 11:00:16 AM
- Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024 • GlobeNewswire Inc. • 05/15/2024 11:00:14 AM
- Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15 • GlobeNewswire Inc. • 05/09/2024 11:00:12 AM
- Renalytix Announces Financing with Expected Size of up to $4 Million • GlobeNewswire Inc. • 04/08/2024 11:00:23 AM
- KidneyIntelX™ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD) • GlobeNewswire Inc. • 03/14/2024 11:00:45 AM
- Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024 • GlobeNewswire Inc. • 02/15/2024 12:00:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 12:00:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:31:06 PM
- Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference • GlobeNewswire Inc. • 02/09/2024 02:00:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 12:15:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 12:15:09 PM
- New published data demonstrates KidneyIntelX™ has broad implications for winning war on chronic kidney disease • GlobeNewswire Inc. • 01/10/2024 12:00:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 09:02:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 11/17/2023 09:01:52 PM
- Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024 • GlobeNewswire Inc. • 11/14/2023 12:00:24 PM
- Renalytix to Report Financial Results for First Quarter Fiscal Year 2024 on November 14 • GlobeNewswire Inc. • 11/07/2023 12:00:59 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/03/2023 08:04:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 12:00:11 PM
- US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to Renalytix • GlobeNewswire Inc. • 10/06/2023 11:00:19 AM
- Renalytix Reports Full Year Fiscal 2023 Results • GlobeNewswire Inc. • 09/28/2023 11:00:49 AM
- Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2023 on September 28 • GlobeNewswire Inc. • 09/25/2023 11:00:40 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 08:04:50 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM